U.S. market Closed. Opens in 4 hours 58 minutes

HARP | Harpoon Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue31.91M23.65M17.44M5.78M4.75M708.00KN/A
Cost of Revenue3.10M2.65MN/AN/AN/AN/AN/A
Gross Profit28.82M21.01M17.44M5.78M4.75MN/AN/A
Operating Expenses100.24M90.45M68.78M63.98M32.47M17.24MN/A
Selling, General & Admin18.85M18.33M16.21M22.39M6.11M3.61M3.37M
Research & Development81.39M72.12M52.56M41.59M26.37M13.62M7.78M
Other Operating Expenses-182.00K-210.00K-26.00K-42.00K-37.00KN/AN/A
Operating Income-68.33M-116.75M-51.33M-58.21M-27.72M-16.53M-11.15M
Other Expenses / Income594.00K30.00K1.42M2.63M-37.00K-302.00K-259.00K
Before Tax Income-67.73M-116.72M-49.91M-55.57M-27.37M-16.83M-11.41M
Income Tax Expenses-594.00K49.71M-3.53M-3.58M358.00KN/AN/A
Net Income-67.14M-166.44M-46.38M-52.00M-27.37M-16.83M-11.41M
Interest Expenses-594.00KN/AN/AN/AN/A285.00K261.00K
Basic Shares Outstanding3.32M3.23M2.50M2.17M2.39M6.90M9.45M
Diluted Shares Outstanding3.32M3.23M2.50M2.17M2.39M6.90M9.45M
EBITDA-68.33M-14.65M-51.33M-58.21M-27.37M-16.18M-10.95M
EBITDA Margin-214.08%-61.95%-294.26%-1,007.55%-576.13%-2,285.17%0.00%
EBIT-68.33M-116.72M-49.91M-55.57M-27.01M-16.55M-11.14M
EBIT Margin-214.08%-493.45%-286.10%-961.95%-568.59%-2,336.86%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙